Role of Mitochondria in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) affects about 30% of the general population in the United States and includes a spectrum of disease that includes simple steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. Significant insight has been gained into our understanding of the...
Main Authors: | Nassir, Fatiha, Ibdah, Jamal A. |
---|---|
Format: | Online |
Language: | English |
Published: |
Molecular Diversity Preservation International (MDPI)
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057755/ |
Similar Items
-
Sirtuins and nonalcoholic fatty liver disease
by: Nassir, Fatiha, et al.
Published: (2016) -
Diabetes and Nonalcoholic Fatty Liver Disease
by: Kantartzis, Konstantinos, et al.
Published: (2012) -
Probiotics and Nonalcoholic Fatty liver Disease
by: Eslamparast, Tannaz, et al.
Published: (2013) -
Role of Mitochondria in HIV Infection and Associated Metabolic Disorders: Focus on Nonalcoholic Fatty Liver Disease and Lipodystrophy Syndrome
by: Pérez-Matute, P., et al.
Published: (2013) -
Role of bioactive fatty acids in nonalcoholic fatty liver disease
by: Juárez-Hernández, Eva, et al.
Published: (2016)